Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study

M Cruijsen; W J F M van der Velden; A F J de Haan; S K Klein; M Hoogendoorn; Y Tromp; B de Valk; B van Rees; F de Boer; E van der Spek; J Pruijt; L F Verdonck; E Vellenga; N Blijlevens; A A van de Loosdrecht; G Huls

doi:10.1080/10428194.2020.1775217

Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study

M Cruijsen^*, W J F M van der Velden, A F J de Haan, S K Klein, M Hoogendoorn, Y Tromp, B de Valk, B van Rees, F de Boer, E van der Spek, J Pruijt, L F Verdonck, E Vellenga, N Blijlevens, A A van de Loosdrecht, G Huls

^*Corresponding author voor dit werk

Onderzoeksoutput › Academic › peer review

139 Downloads (Pure)

Originele taal-2	English
Pagina's (van-tot)	2752-2755
Aantal pagina's	4
Tijdschrift	Leukemia & Lymphoma
Volume	61
Nummer van het tijdschrift	11
Vroegere onlinedatum	1-jun.-2020
DOI's	https://doi.org/10.1080/10428194.2020.1775217
Status	Published - nov.-2020

Toegang tot document

10.1080/10428194.2020.1775217

Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands the OCEAN studyFinal publisher's version, 1,04 MBLicentie: Taverne

Handle.net

Permanente koppeling

Citeer dit

Cruijsen, M., van der Velden, W. J. F. M., de Haan, A. F. J., Klein, S. K., Hoogendoorn, M., Tromp, Y., de Valk, B., van Rees, B., de Boer, F., van der Spek, E., Pruijt, J., Verdonck, L. F., Vellenga, E., Blijlevens, N., van de Loosdrecht, A. A., & Huls, G. (2020). Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study. Leukemia & Lymphoma, 61(11), 2752-2755. https://doi.org/10.1080/10428194.2020.1775217

@article{6f5894967d1d40a0a479356e1e47405c,

title = "Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study",

keywords = "RISK MYELODYSPLASTIC SYNDROMES, CANCER, MDS",

author = "M Cruijsen and {van der Velden}, {W J F M} and {de Haan}, {A F J} and Klein, {S K} and M Hoogendoorn and Y Tromp and {de Valk}, B and {van Rees}, B and {de Boer}, F and {van der Spek}, E and J Pruijt and Verdonck, {L F} and E Vellenga and N Blijlevens and {van de Loosdrecht}, {A A} and G Huls",

year = "2020",

month = nov,

doi = "10.1080/10428194.2020.1775217",

language = "English",

volume = "61",

pages = "2752--2755",

journal = "Leukemia & Lymphoma",

issn = "1042-8194",

publisher = "Taylor & Francis Group",

number = "11",

}

Cruijsen, M, van der Velden, WJFM, de Haan, AFJ, Klein, SK, Hoogendoorn, M, Tromp, Y, de Valk, B, van Rees, B, de Boer, F, van der Spek, E, Pruijt, J, Verdonck, LF, Vellenga, E, Blijlevens, N, van de Loosdrecht, AA & Huls, G 2020, 'Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study', Leukemia & Lymphoma, vol. 61, nr. 11, blz. 2752-2755. https://doi.org/10.1080/10428194.2020.1775217

TY - JOUR

T1 - Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands

T2 - the OCEAN study

AU - Cruijsen, M

AU - van der Velden, W J F M

AU - de Haan, A F J

AU - Klein, S K

AU - Hoogendoorn, M

AU - Tromp, Y

AU - de Valk, B

AU - van Rees, B

AU - de Boer, F

AU - van der Spek, E

AU - Pruijt, J

AU - Verdonck, L F

AU - Vellenga, E

AU - Blijlevens, N

AU - van de Loosdrecht, A A

AU - Huls, G

PY - 2020/11

Y1 - 2020/11

KW - RISK MYELODYSPLASTIC SYNDROMES

KW - CANCER

KW - MDS

U2 - 10.1080/10428194.2020.1775217

DO - 10.1080/10428194.2020.1775217

M3 - Comment/Letter to the editor

C2 - 32530341

SN - 1042-8194

VL - 61

SP - 2752

EP - 2755

JO - Leukemia & Lymphoma

JF - Leukemia & Lymphoma

IS - 11

ER -